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Neuronavigation-guided biopsyMarburg's disease (MD) is an extremely rare and aggressive form ofmultiple sclerosis (MS). In some cases,
MD presents with tumefactive demyelinating lesions with a “tumor-like” appearance in MRI images, for
which itmay be difﬁcult to achieve a form of differential diagnosis between deﬁnitive tumors or abscesses.
Here we report a case of MD histopathologically conﬁrmed after neuronavigationguided biopsy.
Postoperative course was uneventful and following discharge, the patient attended outpatient follow-up
appointments and received i.v. cyclophopsphamide, achieving progressive clinical remission.Anine-month
follow-up brain MRI scan with gadolinium showed no signs of progressing demyelinating disease with an
evident reduction of the biopsied lesion, and almost complete retrogression of the other two lesions.
In our opinion, and through the analysis of currently available literature, early neuronavigation-guided
biopsy is a highly recommend, valuable, and safe diagnostic tool; it is also preferable to stereotactic biopsy,
since its beneﬁts include a very low bleeding rate and brain damage risk, with minimum mortality and
morbidity rates. It also allows the identiﬁcation of the speciﬁc histological pattern, helping to select the best
medical treatment approach and contributing to increase patient outcome and life expectancy.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction“Pseudotumoral demyelinating lesions” comprise various forms
acute demyelinating processes characterized by signiﬁcant difﬁculties
in reaching a differential diagnosis excluding gliomas, tumors and
abscesses [1]. Two nosological entities, Marburg’s disease (MD) and
acute disseminated encephalomyelitis (ADEM), are associated with
similar ﬁndings.WhileMD affects exclusively whitematter ﬁbers, grey
matter involvement is not unusual inADEM;moreover, theonset of the
latter often occurs following infection or vaccination. MD is an
extremely rare and aggressive form of Multiple Sclerosis (MS) with
acute onset, rapid and severe neurological deterioration, and poor
prognosis, usually less than one year. From a histopathological point of
view, MD is similar to classical MS, but lesions are often bigger with
more inﬂammatory inﬁltrates. In some cases, MD presents with a
single, voluminous lesion with perilesional edema. In magnetic
resonance (MRI) images, MD lesions display mild focal enhancement
or typical ring enhancement. Furthermore, the rapid neurologicalrtment of Experimental
mo, Italy. Via del Vespro
pino).
.V. This is an open access article udeterioration coincides with a fast growth rate on MRI. The deﬁnite
diagnosis is often delayed, possibly due to the atypical clinical and
radiological aspects described above. In recent years, there has been
increasing interest inuseof surgical biopsies to reacha certain andearly
diagnosis, in order to determine the appropriate therapeutic approach
avoiding unnecessary surgical or radiation treatment [2,3]. Here we
report a histopathologically conﬁrmed case of MD. Furthermore, we
discuss measures to improve the diagnostic procedure and timing of
best treatment to improve the prognosis, through the analysis of
currently available literature.
Case report
A 24-year-old woman presented with a sudden onset of speaking
difﬁculties and hemifacial numbness on the right side. Her past
medical history was unremarkable, and she was not taking any
medications at the time. A neurological exam at admission revealed
mild right facial deﬁcit and borderline motor aphasia. After a few
hours, a rapid neurological deterioration with mild pyramidal right
hemiparesis and complete aphasia were observed. The patient
underwent a brain CT scan that showed three vague hypodense
lesions: a large one in the left frontal white matter, and two smaller
lesions in theparietal and the rightparatrigonalwhitematter. OnMRInder the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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matter appeared as highly hyperintense on TSE-T2 and FLAIR-T2
sequences, hypointense on TSE-T1, and responsible for a moderate
mass effect on the surrounding structures with incomplete ring
enhancement and choroid plexus involvement, possibly due to
congestion. The frontal lesion showed a pseudotumoral aspect, was
mildly hyperintense on TSE-T2 and FLAIR-T2, strongly hyperintense
on DWI with atypical patchy enhancement (Fig. 1A–B). Our ﬁrst
hypothesis was ADEM or a severe form of MS. Differential diagnostic
options included tumors and abscesses. Thus the patient underwent
total body CT scan that did not reveal additional lesions. Blood
chemistry screens did not reveal any abnormalities. Autoantibodies
and virology testing in the blood and in the cerebrospinal ﬂuid (CSF)
were negative, but agarose gel isoelectric focusing detected the
presence of oligoclonal bands in the CSF. So, we hypothesized an
acute form of demyelinating disease. The patient was therefore
treated with steroids without signiﬁcant improvement. Taking into
account all data, we performed a neuronavigation-assisted biopsy of
the main lesion using an open microsurgical approach. On the day
before the surgery,markerswere positioned on the patient’s scalp for
neuronavigation guidance. Preoperative planning was then carried
out using a contrast agent-enhanced computed tomography (CT)
scan of the brain. The obtained CT images were transferred to a data
storage device, and subsequently were inserted into the neuronavi-
gator. After anaesthesia induction, the principal landmarks estab-
lished during the planning phasewere identiﬁed. A neuronavigation-
assisted parietotemporal craniotomy was performed, followed by a
small corticectomy centered on the lesion. The affected gelatinous
and whitish portion of tissue was identiﬁed at a depth of about 2 cm,
removed in small fragments and sent for histological analysis. A
postoperative CT scan ruled out any complications and the
postoperative course was uneventful (Fig. 1C).
Neurological exam at discharge was slightly better, with partial
reversion of the hemiparesis and improved speech function. The
histopathological report conﬁrmed our hypothesis of MD.Fig. 1. a–b: Pseudotumoral aspect of the left fronto-parietal lesion. c: Immediate posto
progressing demyelinating disease and almost complete retrogression of the other twoImmunohistochemistrywas performed on thin sections to evaluate
the presence of glial ﬁbrillary acidic protein (GFAP), related to reactive
astrocytosis, and of myelin basic protein (MBP), typically absent in
demyelinating areas.Markedgliosis and large areas of demyelination in
thewhitematter, characterized by the absence ofMBP, were observed.
Immunohistochemistry was also performed to determine positivity
for the CD3 and CD68 antigens, expressed in perivascular T-lympho-
cytes and macrophages, respectively. Isolate perivascular lymphocyte
inﬁltration with a marked gliosis was observed as a result of a massive
reactive astrocytosis. Based on the pathological classiﬁcation system
proposed by theMultiple Sclerosis Lesion Project (MSLP) [4], the lesion
could be graded as pattern I (T-cell/macrophage-associated).
Following discharge, the patient attended outpatient follow-up
appointments and received i.v. cyclophosphamide, achieving pro-
gressive clinical remission. A nine-month follow-up brain MRI scan
with gadolinium showed no signs of progressing demyelinating
disease with an evident reduction of the biopsied lesion, displaying
low peripheral enhancement, nearly absent mass effect, and almost
complete retrogression of the other two lesions (Fig. 1D-E).Discussion
Four immunopathological patterns of demyelinating disease have
been proposed by Lucchinetti in the Multiple Sclerosis Lesion Project
(MSLP) [4]. These patterns are related to the grade of myelin protein
loss, the geography and extension of plaques, the extent of
oligodendrocyte destruction, and the immunopathological evidence
of complement activation. The classiﬁcation described by Lucchinetti
is useful for diagnostic and therapeutic purpose. Pattern I is T-cell/
macrophage associated; pattern II is antibody/complement associat-
ed and shows similarities with T-cell plus antibody-mediated
autoimmune encephalomyelitis; pattern III is expression of distal
oligodendrogliopathy; in pattern IV there is oligodendrocyte dystro-
phy in the periplaque white matter. These last two patterns areperative CT scan. d–e: Nine-month follow-up brain MRI scan showing no signs of
lesions.
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autoimmune process.
Maybe, as suggested by Barnett (2004) [5], all demyelinating
lesions originate from a widespread apoptosis of the oligodendro-
cytes without contemporary active inﬂammatory demyelinaton
signs, and only subsequently theyevolve into oneof the four patterns.
There is no clear relationship between the speciﬁc immunopath-
ological feature and the clinical course with its related prognosis.
However, the use of surgical biopsy for anatomopathological
characterization of the demyelinating lesions, is necessary for the
best therapeuticmanagement and,ﬁnally, to ameliorate theoutcome.
For this reason even if classically considered an exclusively
neurological pathology, MS has recently become a disorder of
growing importance for neurosurgeons. In fact, in the rare cases
characterized by a sudden onset of neurological symptoms
associated with tumefactive demyelinating lesions with a “tumor-
like” appearance in MRI images, reaching a deﬁnitive differential
diagnosis is difﬁcult; moreover, oligoclonal bands may be absent in
the CSF, albeit extremely rarely [1]. In previous reports several
demyelinating lesions have been described as “tumor-like” from a
clinical point of view, and especially in relation to their distinctive
radiological features [1,2]. Young adults are more frequently
affected. Although diagnostic approaches without biopsy have
been attempted by employing more and more sophisticated
radiological studies and CSF analyses, histological evaluation is
still essential to achieve a deﬁnite diagnosis in some of the more
complicated cases. Stereotactic or neuronavigation-guided biopsies
are considered two of the least invasive approaches, offering low
bleeding, mortality and morbidity rates. Moreover, obtaining and
analysing a tissue specimen is sure to lead to an almost certain
diagnosis. A previous study by Maarouf and colleagues [2], carried
out in a population of six patients with pseudotumoral demyelin-
ating lesions that were treated surgically (ﬁve stereotactic biopsies
and one microsurgical resection), reported no postoperative
complications, and improved clinical courses in all cases after a
few months of adequate therapy. In one case, the results of a
neurological examination after three months were almost normal.
The mean mortality rate associated with stereotactic biopsies is
estimated in current literature to be about 0.8%, following the
introduction of CT and MR imaging-based surgical planning.
Maarouf and colleagues reported a bleeding rate of 0.5% [2].
Based on the analysis of the literature, the majority of patholog-
ically conﬁrmed cases of tumefactive demyelinating lesions are
diagnosed through open craniotomies [6] and stereotactic biopsies
[2], and, only rarely, through neuronavigation-assisted biopsies [3].
This is surprising since neuronavigation may simplify the surgical
procedure, carries low surgical risks and provides a reliable
histological diagnosis.Considering the total duration of the surgical procedure, the
related risks, and the possibility of obtaining suitable samples,
neuronavigation should be the preferred biopsy technique, according
to both our experience and the available literature. The advantages
consist in: 1) neuronavigation assisted biopsy can be performed also
in a department without access to stereotactic equipment, 2) may be
less costly and less time consuming than stereotactic procedures;
indeed, although the neuronavigation-guided procedure may seem
to entail a longer surgical time, the lengthy planning phase of the
stereotactic approach greatly extends the overall duration of the
latter procedure. Moreover, due to the enhanced ﬁeld of view,
neuronavigation allows for superior bleeding control and the
collection of larger samples that are better suited for histopatholog-
ical evaluation. Because of these advantages, neurologists (and
neurosurgeons) may consider biopsy as a diagnostic tool more
frequently than it is current clinical practice.
Disadvantages of this technique consist in: 1) limited accuracy, as
compared with stereotaxy, especially for small lesions, 2) the lack of
clinical trials comparing neuronavigation techniques and
classical stereotaxy.
On the basis of the available data, the standard initial therapeutic
management of MS should be pharmacological. However, in some
atypical cases, CSF analysis, MRI imaging and/or clinical evaluation
are not sufﬁcient to rule out tumors or abscesses. Positivity for
oligloclonal bands is not an exclusive characteristic of demyelinating
processes, since it can also be related to malignant tumors;
furthermore, not all demyelinating lesions are associated with
oligoclonal band positivity. Radiologic evaluation is often insufﬁcient,
especially in cases with large and/or isolated lesions with atypical
enhancement after contrast medium administration.
Our case illustrates that in such cases early neuronavigation-
guided biopsy may serve as a valuable and safe diagnostic tool.References
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